Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-30

Clinical Trial Update: Treatment of Persisting Symptoms After Concussion With Psilocybin Assisted Therapy [Phase 1]

View source ↗

Summary

Phase 1 study evaluating psilocybin-assisted therapy for persisting symptoms after concussion is currently recruiting. It explores safety and potential efficacy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Psilocybin (psilocybin)

Snippet

Sponsor: University of Calgary | Conditions: Persisting Symptoms After Concussion | Phase 1 | Status: RECRUITING